array:23 [
  "pii" => "S0365059624000412"
  "issn" => "03650596"
  "doi" => "10.1016/j.abd.2023.07.006"
  "estado" => "S300"
  "fechaPublicacion" => "2024-07-01"
  "aid" => "927"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2024"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "pt" => array:18 [
      "pii" => "S2666275224000596"
      "issn" => "26662752"
      "doi" => "10.1016/j.abdp.2024.03.014"
      "estado" => "S300"
      "fechaPublicacion" => "2024-07-01"
      "aid" => "927"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "pt" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Cartas &#8208; Tropical&#47;Infectoparasit&#225;ria</span>"
        "titulo" => "S&#237;filis secund&#225;ria ocorrendo sob terapia anti&#8208;CD20&#58; riscos&#44; progress&#227;o e abordagem"
        "tienePdf" => "pt"
        "tieneTextoCompleto" => "pt"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "632"
            "paginaFinal" => "634"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "pt" => true
        ]
        "contienePdf" => array:1 [
          "pt" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0015"
            "etiqueta" => "Figura 3"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr3.jpeg"
                "Alto" => 834
                "Ancho" => 1505
                "Tamanyo" => 210982
              ]
            ]
            "descripcion" => array:1 [
              "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Colarete de Biett exuberante sobre les&#245;es maculopapulares eritematosas nas palmas das m&#227;s&#44; punhos e &#40;B&#41;&#160;plantas dos p&#233;s&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Luiz Augusto Fabricio de Melo Garbers, Tissiana Marques de Haes, Cacilda da Silva Souza"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Luiz Augusto Fabricio de Melo"
                "apellidos" => "Garbers"
              ]
              1 => array:2 [
                "nombre" => "Tissiana Marques de"
                "apellidos" => "Haes"
              ]
              2 => array:2 [
                "nombre" => "Cacilda da"
                "apellidos" => "Silva Souza"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "pt"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S0365059624000412"
          "doi" => "10.1016/j.abd.2023.07.006"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624000412?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275224000596?idApp=UINPBA00008Z"
      "url" => "/26662752/0000009900000004/v1_202406100414/S2666275224000596/v1_202406100414/pt/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0365059624000679"
    "issn" => "03650596"
    "doi" => "10.1016/j.abd.2023.07.010"
    "estado" => "S300"
    "fechaPublicacion" => "2024-07-01"
    "aid" => "938"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter - Therapy</span>"
      "titulo" => "Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "635"
          "paginaFinal" => "637"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1683
              "Ancho" => 2508
              "Tamanyo" => 325194
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0005"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Clinical photograph of female pediatric patient with pRIA and pCIA before treatment&#44; showing diffuse alopecia with thin hairs&#46; &#40;B&#41; Clinical image of the same patient after one year of treatment with LDOM showing improvement of hair density&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ra&#237;ssa Rodriguez Melo, Rita Fernanda Cortez de Almeida, Luciana Rodino Lemes, Sidney Frattini Junior, Paulo M&#252;ller Ramos, Daniel Fernandes Melo"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Ra&#237;ssa Rodriguez"
              "apellidos" => "Melo"
            ]
            1 => array:2 [
              "nombre" => "Rita Fernanda"
              "apellidos" => "Cortez de Almeida"
            ]
            2 => array:2 [
              "nombre" => "Luciana Rodino"
              "apellidos" => "Lemes"
            ]
            3 => array:2 [
              "nombre" => "Sidney"
              "apellidos" => "Frattini Junior"
            ]
            4 => array:2 [
              "nombre" => "Paulo"
              "apellidos" => "M&#252;ller Ramos"
            ]
            5 => array:2 [
              "nombre" => "Daniel Fernandes"
              "apellidos" => "Melo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "pt" => array:9 [
        "pii" => "S2666275224000705"
        "doi" => "10.1016/j.abdp.2024.04.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "pt"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275224000705?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624000679?idApp=UINPBA00008Z"
    "url" => "/03650596/0000009900000004/v2_202407191005/S0365059624000679/v2_202407191005/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0365059624000424"
    "issn" => "03650596"
    "doi" => "10.1016/j.abd.2023.07.007"
    "estado" => "S300"
    "fechaPublicacion" => "2024-07-01"
    "aid" => "928"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter - Tropical&#47;Infectious and parasitic dermatology</span>"
      "titulo" => "Overdosage of PPD immunotherapy causing tuberculosis-like skin lesions<span class="elsevierStyleSup">&#8902;</span>"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "629"
          "paginaFinal" => "631"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0020"
          "etiqueta" => "Fig&#46; 4"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr4.jpeg"
              "Alto" => 451
              "Ancho" => 1505
              "Tamanyo" => 71601
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at0020"
              "detalle" => "Fig&#46; "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">&#40;A and B&#41; Clinical appearance after surgical excision of the lesions &#40;two months postoperatively&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "John Verrinder Veasey, Vict&#243;ria Cerqueira Elia, Ana Estela Ribeiro, Rute Facchini Lellis"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "John Verrinder"
              "apellidos" => "Veasey"
            ]
            1 => array:2 [
              "nombre" => "Vict&#243;ria Cerqueira"
              "apellidos" => "Elia"
            ]
            2 => array:2 [
              "nombre" => "Ana Estela"
              "apellidos" => "Ribeiro"
            ]
            3 => array:2 [
              "nombre" => "Rute Facchini"
              "apellidos" => "Lellis"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "pt" => array:9 [
        "pii" => "S2666275224000602"
        "doi" => "10.1016/j.abdp.2024.03.015"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "pt"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275224000602?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624000424?idApp=UINPBA00008Z"
    "url" => "/03650596/0000009900000004/v2_202407191005/S0365059624000424/v2_202407191005/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter - Tropical&#47;Infectious and parasitic dermatology</span>"
    "titulo" => "Secondary syphilis occurring under anti-CD20 therapy&#58; risks&#44; progression and approach"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "632"
        "paginaFinal" => "634"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Luiz Augusto Fabricio de Melo Garbers, Tissiana Marques de Haes, Cacilda da Silva Souza"
        "autores" => array:3 [
          0 => array:3 [
            "nombre" => "Luiz Augusto Fabricio de Melo"
            "apellidos" => "Garbers"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Tissiana Marques de"
            "apellidos" => "Haes"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Cacilda da"
            "apellidos" => "Silva Souza"
            "email" => array:1 [
              0 => "cssouza@fmrp.usp.br"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Department of Internal Medicine&#44; Faculdade de Medicina de Ribeir&#227;o Preto&#44; Universidade de S&#227;o Paulo&#44; Ribeir&#227;o Preto&#44; SP&#44; Brazil"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Department of Neurosciences and Behavioral Sciences&#44; Faculdade de Medicina de Ribeir&#227;o Preto&#44; Universidade de S&#227;o Paulo&#44; Ribeir&#227;o Preto&#44; SP&#44; Brazil"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 848
            "Ancho" => 1505
            "Tamanyo" => 267775
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; <span class="elsevierStyleItalic">Corona veneris</span>&#58; thin peripheral desquamation &#40;Biett&#8217;s collarette&#41; over lesions surrounding the forehead&#44; &#40;B&#41; temporal&#44; pre-&#44; intra- and retroauricular regions and &#40;C&#41; base of the neck &#40;white arrows&#41;&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The increasing use of immunotherapies has raised questions regarding changes in the immune response to syphilis in patients receiving these therapies&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">A 22-year-old man using ocrelizumab &#40;anti-CD20&#41; for multiple sclerosis&#44; presented with a non-pruritic skin rash and two febrile episodes 20 days before consultation&#46; When questioned&#44; he mentioned scaly lesions on his hands&#59; erythema and desquamation&#44; without ulceration on the glans&#59; the lesions resolved spontaneously&#44; approximately four weeks after unprotected sexual intercourse&#46; On examination&#44; erythematous-coppery maculopapular lesions were observed on the trunk&#44; some with a central hematic crust on the upper part &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>A&#44;B&#41;&#59; finely scaly lesions surrounding the forehead&#44; temporal&#44; periauricular&#44; and posterior cervical regions&#44; in the shape of a crown &#40;corona veneris&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#44; and with exuberant peripheral desquamation &#40;Biett collarette&#41; on the palms of the hands&#44; soles of the feet and wrists &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>A&#44;B&#41;&#46; These cutaneous and systemic manifestations indicated secondary syphilis&#46; The laboratory investigation showed a low serum titer in the VDRL &#40;Venereal Disease Research Laboratory&#41; test &#40;1&#47;2&#41;&#44; and negativity in the cerebrospinal fluid&#44; with hyperproteinorrhaquia&#44; 56&#8239;mg&#47;dL &#40;15&#8210;45&#8239;mg&#47;dL&#41;&#59; a positive confirmatory chemiluminescence test for treponemal antibodies&#44; and a negative test for human immunodeficiency virus &#40;HIV&#41;&#46; The IgM measurement was reduced&#44; 24&#8239;mg&#47;dL &#40;50&#8210;300&#8239;mg&#47;dL&#41;&#44; and IgA and IgG were normal&#46; Intramuscular benzathine penicillin was recommended&#44; 2&#46;4 million units weekly&#44; for three consecutive weeks&#44; followed by intravenous ceftriaxone&#44; 2&#8239;g daily for 14 days&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Treponema pallidum</span> penetrates through microabrasions in mucous membranes or skin&#44; genital or extragenital&#44; forming a painless ulcer with a hardened base &#40;primary chancre&#41;&#46; Six to ten weeks after the primary infection&#44; secondary syphilis manifests as a polymorphic skin and&#47;or mucosal eruption&#44; lymphadenopathy&#44; and other nonspecific systemic symptoms&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Serological non-treponemal screening tests &#40;VDRL&#44; RPR &#8210; Rapid Test Reagin&#41; and confirmatory treponemal tests &#40;FT-ABS&#44; TPHA &#8210; Treponema Pallidum Hemagglutination Assay&#44; TPPA &#8210; Treponema Pallidum Particle-Agglutination assay&#41; are widely used for the diagnosis of syphilis&#44; and the molecular PCR assay and immunohistochemistry should be considered in the investigation of atypical cases&#44; or conditions in which the humoral response and serological tests may be impaired&#46;<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#44;2</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Ocrelizumab and rituximab are monoclonal antibodies against the CD20 marker on B lymphocytes&#46; Their depletion involves a risk of decreasing immunoglobulin levels and&#44; consequently&#44; the humoral response to neoantigens&#46; After anti-CD20 therapy&#44; B cell recovery is slow and non-uniform&#44; and memory B cells may remain depleted&#46; Compared to ocrelizumab&#44; rituximab was an independent predictor of hypogammaglobulinemia&#44; which may reduce the humoral response&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">A previous report of a patient treated with rituximab for multiple sclerosis and skin eruption typical of secondary syphilis showed negative VDRL and TPPA serological tests on repeated measurements and delayed seroconversion for more than three weeks after the onset of symptoms and skin manifestations&#44; but PCR and immunohistochemistry were positive for <span class="elsevierStyleItalic">T&#46; pallidum</span>&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Reduced humoral response resulting in a delayed seroconversion&#44; low titer or even negative serological tests for syphilis should be expected in patients receiving anti-CD20 class therapy&#46; These conditions can make diagnosis difficult&#44; and clinical manifestations become crucial indicators for suspicion and persistence in the investigation of syphilis&#44; with confirmatory immunohistochemical or molecular tests&#44; and possible involvement of other systems&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">In addition to the six cases in the Iglesias-Plaza review&#44;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> seven more cases of syphilis occurring in patients receiving immunobiological therapy were identified&#46; Most of them were male &#40;9&#41;&#44; aged between 16 and 66 years&#44; with psoriasis and&#47;or psoriatic arthritis &#40;4&#41;&#44; rheumatoid arthritis &#40;2&#41;&#44; juvenile idiopathic arthritis &#40;1&#41;&#44; ankylosing spondylitis &#40;1&#41;&#44; Chron&#8217;s disease&#47;ulcerative rectocolitis &#40;2&#41; and multiple sclerosis &#40;1&#41;&#59; using infliximab &#40;3&#41;&#44; adalimumab &#40;3&#41;&#44; etanercept &#40;2&#41;&#44; ustekinumab &#40;1&#41;&#44; golimumab &#40;1&#41;&#44; tocilizumab &#40;1&#41;&#44; secukinumab &#40;1&#41; and rituximab &#40;1&#41;&#44; according to the respective indications&#46; Among seven investigated cases &#40;7&#47;13&#41;&#44; five cases &#40;71&#46;43&#37;&#41; had confirmation of neurosyphilis&#44; and three were symptomatic&#46; All patients on anti-TNF therapy had positive serological tests&#59; however&#44; immunosuppression is a risk factor for the accelerated course of the disease&#44; and potentially for neurosyphilis &#40;Supplementary Table 1&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3&#8211;8</span></a> The confirmation of neurosyphilis&#44; ocular syphilis or otosyphilis requires the intravenous use of crystalline penicillin G 18 to 24 million units per day&#44; or alternatively ceftriaxone 1&#8239;g to 2&#8239;g daily &#40;intravenously or intramuscularly&#41; for ten to 14 days&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Risk reduction strategies in immunocompromised patients include education and preventive counseling for sexually transmitted infections&#44; in addition to screening and routine serology for immunobiological use&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Syphilis mimicry can bring difficulties for diagnostic suspicion&#44; and there can be rapid progression and challenges in confirming the etiology in those with immunosuppression&#44; requiring meticulous clinical examination&#44; careful laboratory investigation and interpretation&#44; well as the use of additional diagnostic methods&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Financial support</span><p id="par0055" class="elsevierStylePara elsevierViewall">None declared&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Authors&#8217; contributions</span><p id="par0060" class="elsevierStylePara elsevierViewall">Luiz Augusto Fabricio de Melo Garbers&#58; data acquisition&#44; collection&#44; or analysis and interpretation of data&#59; drafting and editing of the manuscript&#59; intellectual participation in the propaedeutic and&#47;or therapeutic conduct of the studied case&#59; approval of the final version of the manuscript&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Tissiana Marques de Haes&#58; Data acquisition&#44; collection&#44; or analysis and interpretation of data&#59; intellectual participation in the propaedeutic and&#47;or therapeutic conduct of the studied case&#59; approval of the final version of the manuscript&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Cacilda da Silva Souza&#58; Design and planning of the study&#59; data acquisition&#44; collection&#44; or analysis and interpretation of data&#59; drafting and editing of the manuscript or critical review of the intellectual content&#59; intellectual participation in the propaedeutic and&#47;or therapeutic conduct of the studied case&#59; critical review of the literature&#59; approval of the final version of the manuscript&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflicts of interest</span><p id="par0075" class="elsevierStylePara elsevierViewall">None declared&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Financial support"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Authors&#8217; contributions"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflicts of interest"
        ]
        3 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2023-05-14"
    "fechaAceptado" => "2023-07-13"
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#8902;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Study conducted at the Hospital das Cl&#237;nicas&#44; Faculty of Medicine&#44; Ribeir&#227;o Preto&#44; Universidade de S&#227;o Paulo&#44; Ribeir&#227;o Preto&#44; SP&#44; Brazil&#46;</p>"
      ]
    ]
    "apendice" => array:1 [
      0 => array:1 [
        "seccion" => array:1 [
          0 => array:4 [
            "apendice" => "<p id="par0085" class="elsevierStylePara elsevierViewall">The following is Supplementary data to this article&#58;<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>"
            "etiqueta" => "Appendix A"
            "titulo" => "Supplementary material"
            "identificador" => "sec0025"
          ]
        ]
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 724
            "Ancho" => 1505
            "Tamanyo" => 207032
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Erythematous&#47;copper-colored macules and papules on the trunk&#59; &#40;B&#41; Lesions with overlapping central hematic crust on the upper part&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 848
            "Ancho" => 1505
            "Tamanyo" => 267775
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; <span class="elsevierStyleItalic">Corona veneris</span>&#58; thin peripheral desquamation &#40;Biett&#8217;s collarette&#41; over lesions surrounding the forehead&#44; &#40;B&#41; temporal&#44; pre-&#44; intra- and retroauricular regions and &#40;C&#41; base of the neck &#40;white arrows&#41;&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 834
            "Ancho" => 1505
            "Tamanyo" => 206722
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Exuberant Biett&#8217;s collarette over erythematous maculopapular lesions on the palms&#44; wrists&#44; and &#40;B&#41; soles of feet&#46;</p>"
        ]
      ]
      3 => array:5 [
        "identificador" => "upi0005"
        "tipo" => "MULTIMEDIAECOMPONENTE"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "Ecomponente" => array:2 [
          "fichero" => "mmc1.docx"
          "ficheroTamanyo" => 24024
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:9 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "V&#46; Mears"
                            1 => "C&#46; Jakubecz"
                            2 => "C&#46; Seeco"
                            3 => "S&#46; Woodson"
                            4 => "A&#46; Serra"
                            5 => "H&#46; Abboud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Neuroimmunol"
                        "fecha" => "2023"
                        "volumen" => "377"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serological diagnosis of secondary syphilis in a Rituximab-treated patient&#58; an emerging diagnostic challenge&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Lefeuvre"
                            1 => "A&#46; Crou&#233;"
                            2 => "P&#46; Abgueguen"
                            3 => "M&#46; Letzelter"
                            4 => "A&#46; Ducancelle"
                            5 => "P&#46; Grange"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.17126"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2021"
                        "volumen" => "35"
                        "paginaInicial" => "e350"
                        "paginaFinal" => "e352"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33462864"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Syphilis in the setting of anti-tumor necrosis factor alpha therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Iglesias-Plaza"
                            1 => "M&#46; Iglesias-Sancho"
                            2 => "M&#46; Quintana-Codina"
                            3 => "J&#46; Garc&#237;a-Miguel"
                            4 => "M&#46; Salleras-Redonnet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.reuma.2017.12.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Reumatol Clin &#40;Engl Ed&#41;"
                        "fecha" => "2019"
                        "volumen" => "15"
                        "paginaInicial" => "e108"
                        "paginaFinal" => "e110"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29398464"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Re-emergence of syphilis in the biological era"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46;F&#46; Pedrosa"
                            1 => "S&#46; Magina"
                            2 => "F&#46; Azevedo"
                            3 => "C&#46; Lisboa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ijd.13389"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol"
                        "fecha" => "2016"
                        "volumen" => "55"
                        "paginaInicial" => "e626"
                        "paginaFinal" => "e628"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27496611"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Secondary syphilis infection under treatment with ustekinumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "U&#46; Uslu"
                            1 => "F&#46; Heppt"
                            2 => "M&#46; Sticherling"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ced.13189"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Dermatol"
                        "fecha" => "2017"
                        "volumen" => "42"
                        "paginaInicial" => "836"
                        "paginaFinal" => "838"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28866870"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A rare case of malignant syphilis after adalimumab therapy due to Crohn&#8217;s disease associated with bariatric surgery"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "I&#46;K&#46; Y&#305;ld&#305;zhan"
                            1 => "H&#46;E&#46; &#350;anl&#305;"
                            2 => "H&#46; &#199;etinkaya"
                            3 => "B&#46;N&#46; Akay"
                            4 => "P&#46; Ko&#231;yi&#287;it"
                            5 => "N&#46; Kundak&#231;&#305;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.diagmicrobio.2019.04.009"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diagn Microbiol Infect Dis"
                        "fecha" => "2019"
                        "volumen" => "95"
                        "paginaInicial" => "89"
                        "paginaFinal" => "92"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31279583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Malignant syphilis in a young patient with juvenile idiopathic arthritis under biological therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "C&#46;A&#46; Dos Santos"
                            1 => "L&#46;C&#46; Benevides"
                            2 => "R&#46;N&#46; Cardili"
                            3 => "G&#46;C&#46;S&#46; Pileggi"
                            4 => "V&#46;P&#46;L&#46; Ferriani"
                            5 => "A&#46;M&#46;F&#46; Roselino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/RHU.0000000000001495"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Rheumatol"
                        "fecha" => "2021"
                        "volumen" => "27"
                        "paginaInicial" => "S382"
                        "paginaFinal" => "S383"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32701535"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The great imitator&#58; latent neurosyphilis revealed after initiation of the immunosuppressive drug secukinumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Duncan"
                            1 => "N&#46; Zingas"
                            2 => "A&#46; Ahmed"
                            3 => "R&#46; Shih"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Cureus"
                        "fecha" => "2021"
                        "volumen" => "13"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Centers for disease control and prevention&#46; Sexually transmitted infections treatment guidelines&#44; 2021&#46; Division of STD prevention&#44; national center for HIV&#44; Viral Hepatitis&#44; STD&#44; and TB prevention&#44; centers for disease control and prevention&#46; &#91;Cited 28 June 2023&#93; Available from&#58; <a target="_blank" href="https://www.cdc.gov/std/treatment-guidelines/syphilis.htm">https&#58;&#47;&#47;www&#46;cdc&#46;gov&#47;std&#47;treatment-guidelines&#47;syphilis&#46;htm</a>&#46;"
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/03650596/0000009900000004/v2_202407191005/S0365059624000412/v2_202407191005/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "95150"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letter - Tropical&#47;Infectious and parasitic dermatology"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03650596/0000009900000004/v2_202407191005/S0365059624000412/v2_202407191005/en/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624000412?idApp=UINPBA00008Z"
]
Compartilhar
Informação da revista
Vol. 99. Núm. 4.
Páginas 632-634 (1 julho 2024)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
2161
Vol. 99. Núm. 4.
Páginas 632-634 (1 julho 2024)
Letter - Tropical/Infectious and parasitic dermatology
Acesso de texto completo
Secondary syphilis occurring under anti-CD20 therapy: risks, progression and approach
Visitas
2161
Luiz Augusto Fabricio de Melo Garbersa, Tissiana Marques de Haesb, Cacilda da Silva Souzaa,
Autor para correspondência
cssouza@fmrp.usp.br

Corresponding author.
a Department of Internal Medicine, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
b Department of Neurosciences and Behavioral Sciences, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
Este item recebeu
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (3)
Mostrar maisMostrar menos
Material adicional (1)
Texto Completo
Dear Editor,

The increasing use of immunotherapies has raised questions regarding changes in the immune response to syphilis in patients receiving these therapies.

A 22-year-old man using ocrelizumab (anti-CD20) for multiple sclerosis, presented with a non-pruritic skin rash and two febrile episodes 20 days before consultation. When questioned, he mentioned scaly lesions on his hands; erythema and desquamation, without ulceration on the glans; the lesions resolved spontaneously, approximately four weeks after unprotected sexual intercourse. On examination, erythematous-coppery maculopapular lesions were observed on the trunk, some with a central hematic crust on the upper part (Fig. 1A,B); finely scaly lesions surrounding the forehead, temporal, periauricular, and posterior cervical regions, in the shape of a crown (corona veneris) (Fig. 2), and with exuberant peripheral desquamation (Biett collarette) on the palms of the hands, soles of the feet and wrists (Fig. 3A,B). These cutaneous and systemic manifestations indicated secondary syphilis. The laboratory investigation showed a low serum titer in the VDRL (Venereal Disease Research Laboratory) test (1/2), and negativity in the cerebrospinal fluid, with hyperproteinorrhaquia, 56 mg/dL (15‒45 mg/dL); a positive confirmatory chemiluminescence test for treponemal antibodies, and a negative test for human immunodeficiency virus (HIV). The IgM measurement was reduced, 24 mg/dL (50‒300 mg/dL), and IgA and IgG were normal. Intramuscular benzathine penicillin was recommended, 2.4 million units weekly, for three consecutive weeks, followed by intravenous ceftriaxone, 2 g daily for 14 days.

Figure 1.

(A) Erythematous/copper-colored macules and papules on the trunk; (B) Lesions with overlapping central hematic crust on the upper part.

(0.2MB).
Figure 2.

(A) Corona veneris: thin peripheral desquamation (Biett’s collarette) over lesions surrounding the forehead, (B) temporal, pre-, intra- and retroauricular regions and (C) base of the neck (white arrows).

(0.26MB).
Figure 3.

(A) Exuberant Biett’s collarette over erythematous maculopapular lesions on the palms, wrists, and (B) soles of feet.

(0.2MB).

Treponema pallidum penetrates through microabrasions in mucous membranes or skin, genital or extragenital, forming a painless ulcer with a hardened base (primary chancre). Six to ten weeks after the primary infection, secondary syphilis manifests as a polymorphic skin and/or mucosal eruption, lymphadenopathy, and other nonspecific systemic symptoms.

Serological non-treponemal screening tests (VDRL, RPR ‒ Rapid Test Reagin) and confirmatory treponemal tests (FT-ABS, TPHA ‒ Treponema Pallidum Hemagglutination Assay, TPPA ‒ Treponema Pallidum Particle-Agglutination assay) are widely used for the diagnosis of syphilis, and the molecular PCR assay and immunohistochemistry should be considered in the investigation of atypical cases, or conditions in which the humoral response and serological tests may be impaired.1,2

Ocrelizumab and rituximab are monoclonal antibodies against the CD20 marker on B lymphocytes. Their depletion involves a risk of decreasing immunoglobulin levels and, consequently, the humoral response to neoantigens. After anti-CD20 therapy, B cell recovery is slow and non-uniform, and memory B cells may remain depleted. Compared to ocrelizumab, rituximab was an independent predictor of hypogammaglobulinemia, which may reduce the humoral response.1

A previous report of a patient treated with rituximab for multiple sclerosis and skin eruption typical of secondary syphilis showed negative VDRL and TPPA serological tests on repeated measurements and delayed seroconversion for more than three weeks after the onset of symptoms and skin manifestations, but PCR and immunohistochemistry were positive for T. pallidum.2

Reduced humoral response resulting in a delayed seroconversion, low titer or even negative serological tests for syphilis should be expected in patients receiving anti-CD20 class therapy. These conditions can make diagnosis difficult, and clinical manifestations become crucial indicators for suspicion and persistence in the investigation of syphilis, with confirmatory immunohistochemical or molecular tests, and possible involvement of other systems.

In addition to the six cases in the Iglesias-Plaza review,3 seven more cases of syphilis occurring in patients receiving immunobiological therapy were identified. Most of them were male (9), aged between 16 and 66 years, with psoriasis and/or psoriatic arthritis (4), rheumatoid arthritis (2), juvenile idiopathic arthritis (1), ankylosing spondylitis (1), Chron’s disease/ulcerative rectocolitis (2) and multiple sclerosis (1); using infliximab (3), adalimumab (3), etanercept (2), ustekinumab (1), golimumab (1), tocilizumab (1), secukinumab (1) and rituximab (1), according to the respective indications. Among seven investigated cases (7/13), five cases (71.43%) had confirmation of neurosyphilis, and three were symptomatic. All patients on anti-TNF therapy had positive serological tests; however, immunosuppression is a risk factor for the accelerated course of the disease, and potentially for neurosyphilis (Supplementary Table 1).3–8 The confirmation of neurosyphilis, ocular syphilis or otosyphilis requires the intravenous use of crystalline penicillin G 18 to 24 million units per day, or alternatively ceftriaxone 1 g to 2 g daily (intravenously or intramuscularly) for ten to 14 days.9

Risk reduction strategies in immunocompromised patients include education and preventive counseling for sexually transmitted infections, in addition to screening and routine serology for immunobiological use.

Syphilis mimicry can bring difficulties for diagnostic suspicion, and there can be rapid progression and challenges in confirming the etiology in those with immunosuppression, requiring meticulous clinical examination, careful laboratory investigation and interpretation, well as the use of additional diagnostic methods.

Financial support

None declared.

Authors’ contributions

Luiz Augusto Fabricio de Melo Garbers: data acquisition, collection, or analysis and interpretation of data; drafting and editing of the manuscript; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied case; approval of the final version of the manuscript.

Tissiana Marques de Haes: Data acquisition, collection, or analysis and interpretation of data; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied case; approval of the final version of the manuscript.

Cacilda da Silva Souza: Design and planning of the study; data acquisition, collection, or analysis and interpretation of data; drafting and editing of the manuscript or critical review of the intellectual content; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied case; critical review of the literature; approval of the final version of the manuscript.

Conflicts of interest

None declared.

Appendix A
Supplementary material

The following is Supplementary data to this article:

References
[1]
V. Mears, C. Jakubecz, C. Seeco, S. Woodson, A. Serra, H. Abboud.
Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD.
J Neuroimmunol, 377 (2023),
[2]
C. Lefeuvre, A. Croué, P. Abgueguen, M. Letzelter, A. Ducancelle, P. Grange, et al.
Serological diagnosis of secondary syphilis in a Rituximab-treated patient: an emerging diagnostic challenge?.
J Eur Acad Dermatol Venereol, 35 (2021), pp. e350-e352
[3]
A. Iglesias-Plaza, M. Iglesias-Sancho, M. Quintana-Codina, J. García-Miguel, M. Salleras-Redonnet.
Syphilis in the setting of anti-tumor necrosis factor alpha therapy.
Reumatol Clin (Engl Ed), 15 (2019), pp. e108-e110
[4]
A.F. Pedrosa, S. Magina, F. Azevedo, C. Lisboa.
Re-emergence of syphilis in the biological era.
Int J Dermatol, 55 (2016), pp. e626-e628
[5]
U. Uslu, F. Heppt, M. Sticherling.
Secondary syphilis infection under treatment with ustekinumab.
Clin Exp Dermatol, 42 (2017), pp. 836-838
[6]
I.K. Yıldızhan, H.E. Şanlı, H. Çetinkaya, B.N. Akay, P. Koçyiğit, N. Kundakçı.
A rare case of malignant syphilis after adalimumab therapy due to Crohn’s disease associated with bariatric surgery.
Diagn Microbiol Infect Dis, 95 (2019), pp. 89-92
[7]
C.A. Dos Santos, L.C. Benevides, R.N. Cardili, G.C.S. Pileggi, V.P.L. Ferriani, A.M.F. Roselino.
Malignant syphilis in a young patient with juvenile idiopathic arthritis under biological therapy.
J Clin Rheumatol, 27 (2021), pp. S382-S383
[8]
A. Duncan, N. Zingas, A. Ahmed, R. Shih.
The great imitator: latent neurosyphilis revealed after initiation of the immunosuppressive drug secukinumab.
Cureus, 13 (2021),
[9]
Centers for disease control and prevention. Sexually transmitted infections treatment guidelines, 2021. Division of STD prevention, national center for HIV, Viral Hepatitis, STD, and TB prevention, centers for disease control and prevention. [Cited 28 June 2023] Available from: https://www.cdc.gov/std/treatment-guidelines/syphilis.htm.

Study conducted at the Hospital das Clínicas, Faculty of Medicine, Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Copyright © 2024. Sociedade Brasileira de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
Material Suplementar
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.